- Expertise article
- Patterson et al., 2013
Modified-live vaccine (MLV) can significantly reduce lung lesions following a heterologous PRRSV challenge. It is necessary for PRRS MLV vaccines to be effective against newly emerging PRRSV field isolates. The objective of this report is to summarize experimental data on PRRSV MLV efficacy following challenge with eight genetically diverse PRRSV isolates.
Read the full publication here.